Refine by
Artery Disease Suppliers Serving Rwanda
58 companies found
based inLjubljana, SLOVENIA
We digitalise medical assessment in primary care and beyond. The digital age has opened a new chapter in the quality and efficiency of medical work. We use digital advantages to simplify diagnostics and help healthcare achieve its basic goals: early ...
based inGeleen, NETHERLANDS
Promicol was established in 2000, founded on many years of experience in all aspects of ATP technology. We are based in The Netherlands, centrally located in Europe, with excellent transport facilities and logistic services. We provide systems that ...
The SANYGO whole blood assay provides a rapid test platform for analysis of the measurement of ATP release, which is used to identify patients who may be at risk for platelet based bleeding or thrombotic complications. The current technology in ...
based inBurlington, MASSACHUSETTS (USA)
LeMaitre is a leading global innovator, manufacturer and marketer of devices for the treatment of peripheral vascular disease. We’re proud to provide vascular surgeons with the solutions they need to diagnose and heal their patients. While LeMaitre ...
based inSomerset, NEW JERSEY (USA)
Terumo Interventional Systems (TIS), a division of Terumo Medical Corporation, is a market leader in minimally invasive entry site management, lesion access, and interventional technologies. At Terumo Interventional Systems (TIS), we believe that ...
based inShipley, UNITED KINGDOM
Our founders have more than 50 years of experience in the field of protein and antibody research. They are experts in this niche market and the main purpose behind the creation of this company was to offer customers with the highest quality ...
Human ANP ELISA kit is a procedure intended for determining in vitro quantitative amounts of atrial natriuretic peptide (ANF, ANH, ANP) in human serum, cell lysates, plasma, other biological fluids and cell culture ...
based inJeddah, SAUDI ARABIA
Gulf Medical Company was founded in 1983 as a medical supply company specialized in the sales and marketing of medical devices and equipment, with the sole proprietorship of the vision “To bring the most innovative state of the art medical ...
based inLeeds, UNITED KINGDOM
Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...
based inSaint Nicolas de Redon, FRANCE
Axelife SAS is a French MedTech company since 2010. It designs and develops medical devices, and its flagship product, the pOpmètre®, is a device that diagnoses arteriosclerosis and accelerated vascular ...
The device for measuring arteriosclerosis and accelerated arterial aging based on the central Pulse Wave Velocity, which is a surrogate of the arterial ...
based inWest Chester, PENNSYLVANIA (USA)
Portescap offers best-in-class solutions to meet the motion needs of medical and industrial applications. We serve performance-critical motion applications with a broad offering of miniature electronic motor product technologies – brushless DC, ...
based inIrvine, CALIFORNIA (USA)
Walk Vascular was founded in 2010, with a mission to treat and transform the lives of patients suffering from peripheral arterial and venous disease. Its JETi Thrombectomy System (JETi) is manufactured within The Company's 19,000 sq. ft., Irvine, ...
based inHartford, UNITED KINGDOM
Formed in 1989 APC Cardiovascular has earned a reputation as a successful and well-respected healthcare sales and distribution company. We offer direct sales and support for numerous cardiovascular and cardiology product ranges, supplying ...
Using thoracic electrical bioimpedance, the PhysioFlow™ incorporates unique and patented signal waveform morphology analysis algorithm to measure cardiac output and other hemodynamic parameters, thus overcoming the accuracy problems associated ...
based inSan Diego, CALIFORNIA (USA)
Everyone at AnaBios shares a passion and commitment to make a difference in the development of promising new therapies and cures for patients by reducing the time and expense needed to bring these medicines to patients. We do this by generating ...
The human heart is a complex organ of distinct sub-structures, different tissue types and cellular architectures that work in a coordinated fashion to pump blood throughout the body (Figure 1). Tissue distribution, cellular composition and gene ...
based inLodz, POLAND
Angionica Ltd. is a spin-off company whose main goal is the implementation of the innovative Flow Mediated Skin Fluorescence (FMSF) method developed by Lodz University of Technology (TUL) and the Jagiellonian University (UJ). FMSF is a new ...
The FMSF-HS test allows assessment of microcirculatory status based on analysis of baseline oscillations and the reperfusion signal, showing changes in NADH fluorescence due to induced reactive hyperemia ...
based inRouen, FRANCE
Founded in 2009 by Philippe Bencteux, MD, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases. As an active player in the evolving medical robotic industry, these innovative solutions aim to make medical ...
Innovation is at the heart of Robocath’s strategy, making R-One™ a unique solution, protected by over 60 international ...
based inMonroe Township, NEW JERSEY (USA)
We are a multinational company active in the life science sector, a world leader in imaging diagnostics. Every day we seek and perfect increasingly advanced and sustainable techniques and solutions to open new paths in diagnostic imaging. So that ...
Interventional cardiology is a subspecialty of cardiology that utilizes non-surgical, catheter-based procedures to treat all sorts of heart diseases, such as narrowed arteries, damaged or weakened blood vessels, ...
based inNew Hope, PENNSYLVANIA (USA)
We are a biomedical innovation company focused on developing transformative therapeutic products for large unmet clinical needs in procedure-based medicine. Our partnership-enabled business model focuses on forging strategic collaborations with ...
Virtue SAB is a patented drug/device combination product for the treatment of artery disease that delivers a proprietary extended release formulation of sirolimus, SirolimusEFR, during balloon angioplasty without ...
based inGhislenghien, BELGIUM
DiAgam produces turbidimetric immuno reagents. We are active in the field of Biotechnology. Our R&D department aims its work to developing classical immunology technologies as well as new and innovative technologies based on nanobiotechnologies. ...
C-reactive protein (CRP) is an α1-globulin predominantly synthesized by hepatocytes. It consists of five identical non-glycosylated polypeptide subunits, linked together non-covalently, forming a protein of about 115 kDa. It is composed of few ...
based inBonn, GERMANY
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The ...
The LEGFLOW balloon drug coating quality is a major step beyond contemporary first and second generation DCB ...
based inSão Paulo, BRAZIL
We were born on July, 15, 1994 in Amparo/SP, and the essence of our company is to use state-of -the-art technology to develop equipment for human wellness, in physical rehabilitation, esthetics or esthetic medicine. Today, we are located in a built ...
Hooke is a device designed for the application of radiofrequency energy used in medical and esthetic treatments, with deep or superficial penetration. It is microcontrolled by a frequency of operation of the radiofrequency generator of 27.12MHz and ...
based inChampionsGate, FLORIDA (USA)
Our purpose is to improve health of the patients all around the world with our strong, hardworking, dedicated and clinically driven biomedical solutions team. Our products and technologies are mostly focused on endovascular treatment solutions with ...
is a coronary balloon-expandable Stainless Steel stent system consisting of everolimus particles. It is indicated for de novo and in-stent restenotic lesions in patients with coronary artery disease – ...
